Department of Cardiology, Austin Health, Level 5 North Austin Tower, 145 Studley Road, Heidelberg, Victoria 3084, Australia.
Heart Lung Circ. 2010 Jan;19(1):58-60. doi: 10.1016/j.hlc.2008.12.003. Epub 2009 Feb 27.
Patent foramen ovale (PFO) occurs in up to 30% of the population, making it the most common site for intra-cardiac shunting. The passage of thrombus across a PFO is typically transient, thus is rarely proven. We describe a rare case of a 79-year-old man with thrombus entrapped across a PFO providing a source for ongoing pulmonary and systemic thromboembolism, despite systemic anticoagulation. There is a paucity of literature to guide primary management of this condition. Management options include surgical thrombectomy with PFO closure, thrombolysis and systemic anticoagulation. The role of percutaneous PFO closure devices for secondary prevention of thromboembolic complications is currently under investigation.
卵圆孔未闭(PFO)在人群中的发生率高达 30%,使其成为心内分流的最常见部位。PFO 内血栓的通过通常是短暂的,因此很少被证实。我们描述了一例罕见的 79 岁男性病例,其 PFO 内有血栓嵌顿,尽管全身抗凝,仍持续发生肺和全身血栓栓塞。目前,文献中很少有指南指导这种情况的主要治疗方法。治疗选择包括 PFO 闭合的手术血栓切除术、溶栓和全身抗凝。目前正在研究经皮 PFO 封堵装置在预防血栓栓塞并发症中的作用。